← Open Payments lookup

HANNAH CUMMINS: Open Payments

NPI 1285301408 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,658 in 102 payments from 18 companies in 2025. Trend: 2023 $1,106 · 2024 $1,958 · 2025 $1,658

Food & beverage: $1,658
CompanyPaymentsAmount
ABBVIE INC.29$345
AstraZeneca Pharmaceuticals LP17$313
PFIZER INC.17$243
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$170
Novo Nordisk Inc7$151
Otsuka America Pharmaceutical, Inc.5$88
Astellas Pharma US Inc2$44
Bayer Healthcare Pharmaceuticals Inc.2$41
Edwards Lifesciences Corporation2$40
Amgen Inc.2$35

Products named: VRAYLAR, CAPLYTA, FARXIGA, NURTEC ODT, BREZTRI, REXULTI, PREVNAR 20, Ozempic.

Industry payments across IN — which companies pay providers there.